SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001360865-14-000046
Filing Date
2014-09-23
Accepted
2014-09-23 15:06:08
Documents
1
Period of Report
2012-08-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2107
  Complete submission text file 0001360865-14-000046.txt   3748
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Issuer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2860 Industrial Organic Chemicals

Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address
Mikaelian Arthur G. (Reporting) CIK: 0001619972 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52445 | Film No.: 141115932